Structured evidence table for Olive Leaf Cardiometabolic Markers Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Olive Leaf Cardiometabolic Markers Meta-Analysis | We assessed the data for risk of bias, heterogeneity, sensitivity, reporting bias and quality of evidence. | 1 | Ismail MA (2021) | Olive leaf extract effect on cardiometabolic profile among adults with prehypertension and hypertension: a systematic review and meta-analysis. |
| Olive Leaf Cardiometabolic Markers Meta-Analysis | No significant changes were found between systolic or diastolic blood pressure (BP) for the first comparison, 1,000 mg per day for a combined formulation of olive leaf extract versus a placebo. | 1 | Ismail MA (2021) | Olive leaf extract effect on cardiometabolic profile among adults with prehypertension and hypertension: a systematic review and meta-analysis. |
| Olive Leaf Cardiometabolic Markers Meta-Analysis | Conclusions The results from this review suggest the reduction of systolic BP, LDL and inflammatory biomarkers, but it may not provide a robust conclusion regarding the effects of olive leaf extract on cardiometabolic profile due to the limited number of participants in the included trials. | 1 | Ismail MA (2021) | Olive leaf extract effect on cardiometabolic profile among adults with prehypertension and hypertension: a systematic review and meta-analysis. |
| Olive Leaf Cardiometabolic Markers Meta-Analysis | Background This systematic review and meta-analysis aimed to determine the effectiveness of olive leaf extract on cardiometabolic profiles among prehypertensive and hypertensive groups. | 1 | Ismail MA (2021) | Olive leaf extract effect on cardiometabolic profile among adults with prehypertension and hypertension: a systematic review and meta-analysis. |
| Olive Leaf Cardiometabolic Markers Meta-Analysis | Furthermore, the treatment with the oil mixture (2.5 mL/Kg) and OLE (100 mg/Kg) to 24 month old Wistar rats for 21 days improved the lipid profile, increased the HOMA-IR and decreased the serum levels of miRNAs 21 and 146a. | 4 | González-Hedström D (2021) | Addition of Olive Leaf Extract to a Mixture of Algae and Extra Virgin Olive Oils Decreases Fatty Acid Oxidation and Synergically Attenuates Age-Induced Hypertension, Sarcopenia and Insulin Resistance in Rats. |
| Olive Leaf Cardiometabolic Markers Meta-Analysis | In conclusion, treatment with a new nutraceutical based on a mixture of EVOO, AO and OLE is a useful strategy for improving the stability of n-3 PUFA in the final product and to attenuate the cardiometabolic and muscular disorders associated with aging. | 4 | González-Hedström D (2021) | Addition of Olive Leaf Extract to a Mixture of Algae and Extra Virgin Olive Oils Decreases Fatty Acid Oxidation and Synergically Attenuates Age-Induced Hypertension, Sarcopenia and Insulin Resistance in Rats. |
| Olive Leaf Cardiometabolic Markers Meta-Analysis | Olive-derived products, such as virgin olive oil (EVOO) and/or olive leaf extracts (OLE), exert anti-inflammatory, insulin-sensitizing and antihypertensive properties and may be useful for stabilizing omega 3 fatty acids (n-3 PUFA) due to their high content in antioxidant compounds. | 4 | González-Hedström D (2021) | Addition of Olive Leaf Extract to a Mixture of Algae and Extra Virgin Olive Oils Decreases Fatty Acid Oxidation and Synergically Attenuates Age-Induced Hypertension, Sarcopenia and Insulin Resistance in Rats. |
| Olive Leaf Cardiometabolic Markers Meta-Analysis | In this study, the addition of OLE 4:0.15 ( w /w ) to a mixture of algae oil (AO) rich in n-3 PUFA and EVOO (25:75, w / w ) prevents peroxides formation after 12 months of storage at 30 °C. | 4 | González-Hedström D (2021) | Addition of Olive Leaf Extract to a Mixture of Algae and Extra Virgin Olive Oils Decreases Fatty Acid Oxidation and Synergically Attenuates Age-Induced Hypertension, Sarcopenia and Insulin Resistance in Rats. |
Source documents